CPT code 68530 denotes surgical removal of a foreign body or dacryolith from the lacrimal gland or sac to relieve obstruction of the tear duct. As a targeted ophthalmic surgical procedure, it is used to restore tear drainage, reduce recurrent infections, and resolve chronic tearing that can impair vision and quality of life. Nationally, this code represents a niche but clinically important intervention performed by ophthalmologists and oculoplastic surgeons.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and which payer types commonly cover such surgical lacrimal procedures. The publication outlines billing considerations relevant to surgical services, common modifiers used in practice, and where this code sits in relation to other lacrimal and ophthalmic surgical codes.

This summary equips billing managers, compliance officers, and clinical leaders with an overview of CPT code 68530, its clinical intent, and the payer landscape. It highlights what to expect when preparing claims and documentation for lacrimal duct or sac foreign body removal and points readers toward detailed sections on benchmarks, coding guidance, and clinical indications.